http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102433421-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate | 2020-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102433421-B1 |
| titleOfInvention | Pharmaceutical composition for preventing or treating type 2 diabetes comprising TAZ protein or a variant thereof |
| abstract | It relates to a pharmaceutical composition for preventing or treating type 2 diabetes comprising a TAZ protein or a variant thereof. According to one aspect, the pharmaceutical composition comprising the TAZ protein or a variant thereof can increase insulin sensitivity by enhancing the expression of IRS1 in muscle cells, so it can be used for the prevention, improvement, or treatment of type 2 diabetes. |
| priorityDate | 2020-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 679.